Biotech
> OncoSec Medical ($ONCS) named Richard Slansky as chief financial officer. Release
> Aegerion Pharmaceuticals ($AEGR) appointed Gregory Perry as chief financial officer. Release
> William Duke Jr. joined Pulmatrix ($PULM) as chief financial officer. Release
> Ultragenyx Pharmaceuticals ($RARE) named Daniel Welch as chairman of its board. Release
> Harvard Apparatus Regenerative Technology ($HART) appointed James McGorry as CEO. Release
> Lannett ($LCI) added Albert Paonessa to its board of directors. Release
> PixarBio promoted Jason Criscione to chief technology officer. Release
> PDL Biopharma ($PDLI) appointed Steffen Pietzke as controller and chief accounting officer. Release
> Cheryl Cohen, formerly of Medivation ($MDVN), joined CytRx's ($CYTR) board of directors. Release
> Agios ($AGIO) named Maykin Ho to its board of directors. Release
> Phosplatin Therapeutics appointed Dr. José Jimeno as chief medical officer. Release
> Sphere Medical Holding named David Martyr as its new chairman. Release
> Dr. Kanya Rajangam joined Cleave Biosciences as vice president of clinical development. Chief Medical Officer Dr. Alessandra Cesano is leaving the company. Release
> NuCana appointed Dr. Martin Birkhofer as chief medical officer. Release
> ProNAi Therapeutics appointed Dr. Barbara Klencke as its chief development officer. Release
> Kryptiq brought on Dr. Joseph Siemienczuk as its chief medical officer. Release
> TissueGen appointed Jennifer Seifert as its senior scientist leading the spinal cord injury repair program. Release
> Ambrx named Tiecheng Qiao as its CEO and Feng Tian as its CSO. Release
> Ultragenyx ($RARE) appointed Dr. Jayson Dallas as its chief commercial officer and senior vice president. Release
> Conatus Pharma ($CNAT) appointed Mason Yamashita as its vice president of pharmacovigilance. Release
> Julie Monzo joined Astellas Pharma as a member of corporate affairs. Release
> Chris Martin joined ADC Therapeutics as its CEO. Release
> Bind Therapeutics ($BIND) named Andrew Hirsch as its president and CEO. Release
> Intercept Pharma ($ICPT) appointed Dr. Juan Carlos Lopez-Talavera as its senior vice president of medical affairs. Release
> Clovis Oncology ($CLVS) appointed Lindsey Rolfe as its chief medical officer. Release
Med Tech
> Sebacia hired Pedro Medrano as vice president of engineering and program management. Release
> Second Sight ($EYES) appointed Will McGuire as president and CEO and Dr. Robert Greenberg as chairman of the board. Release
> Medtronic ($MDT) named Geoff Martha as executive vice president and president, Restorative Therapies Group. Release
CRO
> SNBL USA named Monica Vergarra as director of toxicology support services and Charlie Barker its director of scientific services. Release | Release
|